CSIMarket Company Name, Ticker, Customers, else..



Worst Performing Stocks In Total Market Over The Past 12 Months


 1 Day   Week  Current Month of January  30 Days 
Current Quarter Q1 of 2025  90 Days    Ytd    12 Months 
 

Shares are up by 43.53% on average, in Total Market over the past 12 months.

Here are the Worst performing stocks in Total Market.




SYTA

$5.8437

$-619.5843 -99.07%
Last 12 Months


SYTA

$5.8437

$-619.5843 -99.07%



Siyata Mobile Inc

Siyata Mobile Inc stock declined -99.07% over the past 12 months.


Siyata Mobile Inc*s business model focuses on providing innovative communication devices and solutions for commercial vehicles, such as fleet and taxi companies.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 0.007 mill. $ 8.233 mill. $ -12.932 mill. 0 mill. - Y/Y 9.12 %
Market Cap. Revenues TTM Net Income TTM

$ 0.007 mill.
$ 8.233 mill.


$ -12.932 mill.
Employees Shares Outstanding P/E

45
0 mill.
-
Revenue Growth Income Growth

MRQ Y/Y 9.12 %
MRQ Y/Y - %


VMAR

$1.655

$-106.0750 -98.46%
Last 12 Months


VMAR

$1.655

$-106.0750 -98.46%



Vision Marine Technologies inc

Vision Marine Technologies Inc shares dropped -98.46% over the past 12 months.


Vision Marine Technologies Inc. operates as an electric powerboat manufacturer, specializing in the development and production of environmentally friendly, zero-emission electric boats.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 0.114 mill. $ 4.329 mill. $ -15.992 mill. 0 mill. - Y/Y -23.12 %
Market Cap. Revenues TTM Net Income TTM

$ 0.114 mill.
$ 4.329 mill.


$ -15.992 mill.
Employees Shares Outstanding P/E

51
0 mill.
-
Revenue Growth Income Growth

MRQ Y/Y -23.12 %
MRQ Y/Y - %


TCBP

$0.3388

$-20.2442 -98.35%
Last 12 Months


TCBP

$0.3388

$-20.2442 -98.35%



Tc Biopharm holdings Plc

Tc Biopharm Holdings Plc shares went down -98.35% over the past 12 months.


Tc Biopharm Holdings Plc*s business model revolves around the development and commercialization of innovative cell therapies for the treatment of various diseases and medical conditions.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 1.021 mill. $ - mill. $ -10.619 mill. 3 mill. - Y/Y - %
Market Cap. Revenues TTM Net Income TTM

$ 1.021 mill.
$ - mill.


$ -10.619 mill.
Employees Shares Outstanding P/E

42
3 mill.
-
Revenue Growth Income Growth

MRQ Y/Y - %
MRQ Y/Y - %


CETX

$2.656

$-120.1940 -97.84%
Last 12 Months


CETX

$2.656

$-120.1940 -97.84%



Cemtrex Inc

Cemtrex Inc stock dropped -97.84% over the past 12 months.


Cemtrex Inc is a diversified technology company that designs, manufacturers, and sells a range of electronic and industrial products globally. Their business model focuses on providing innovative solutions and services in the areas of environmental monitoring, advanced electronics manufacturing, industrial automation, and intelligent systems.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 2.379 mill. $ 61.380 mill. $ -13.185 mill. 1 mill. - Y/Y -13.66 %
Market Cap. Revenues TTM Net Income TTM

$ 2.379 mill.
$ 61.380 mill.


$ -13.185 mill.
Employees Shares Outstanding P/E

108
1 mill.
-
Revenue Growth Income Growth

MRQ Y/Y -13.66 %
MRQ Y/Y - %


WINT

$0.1895

$-8.0905 -97.71%
Last 12 Months


WINT

$0.1895

$-8.0905 -97.71%



Windtree Therapeutics Inc

Windtree Therapeutics Inc stock declined -97.71% over the past 12 months.


Windtree Therapeutics Inc is a biotechnology company that develops novel gene therapies to treat respiratory diseases by delivering therapeutic proteins to the lungs. They aim to address unmet medical needs and improve the lives of patients through their innovative treatment approaches.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 0.168 mill. $ - mill. $ -9.136 mill. 1 mill. - Y/Y - %
Market Cap. Revenues TTM Net Income TTM

$ 0.168 mill.
$ - mill.


$ -9.136 mill.
Employees Shares Outstanding P/E

19
1 mill.
-
Revenue Growth Income Growth

MRQ Y/Y - %
MRQ Y/Y - %


WNW

$0.2299

$-9.1101 -97.54%
Last 12 Months


WNW

$0.2299

$-9.1101 -97.54%



Meiwu Technology Company Limited

Meiwu Technology Company Limited shares dropped -97.54% over the past 12 months.


Meiwu Technology Company Limited*s business model focuses on providing innovative technology solutions and services.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 10.218 mill. $ 10.979 mill. $ -11.220 mill. 44 mill. - Y/Y 0.00 %
Market Cap. Revenues TTM Net Income TTM

$ 10.218 mill.
$ 10.979 mill.


$ -11.220 mill.
Employees Shares Outstanding P/E

-
44 mill.
-
Revenue Growth Income Growth

MRQ Y/Y 0.00 %
MRQ Y/Y - %


TRNR

$2.4803

$-79.4497 -96.97%
Last 12 Months


TRNR

$2.4803

$-79.4497 -96.97%



Interactive Strength Inc

Interactive Strength Inc shares went down -96.97% over the past 12 months.


Interactive Strength Inc is a company that operates on a business model that focuses on providing interactive and engaging experiences for their clients.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 0.115 mill. $ 3.304 mill. $ -39.580 mill. 0 mill. - Y/Y 537.34 %
Market Cap. Revenues TTM Net Income TTM

$ 0.115 mill.
$ 3.304 mill.


$ -39.580 mill.
Employees Shares Outstanding P/E

-
0 mill.
-
Revenue Growth Income Growth

MRQ Y/Y 537.34 %
MRQ Y/Y - %


TGL

$0.2229

$-6.4341 -96.65%
Last 12 Months


TGL

$0.2229

$-6.4341 -96.65%



Treasure Global Inc

Treasure Global Inc shares declined -96.65% over the past 12 months.


Treasure Global Inc operates as a global conglomerate, primarily focused on acquiring and managing diverse businesses across various industries, with an aim to generate long-term value and profitability. Their business model involves strategic acquisitions, careful management of acquired businesses, and leveraging synergies among different subsidiaries to drive growth and maximize shareholder value.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 0.601 mill. $ 21.981 mill. $ -5.995 mill. 3 mill. - Y/Y -99.33 %
Market Cap. Revenues TTM Net Income TTM

$ 0.601 mill.
$ 21.981 mill.


$ -5.995 mill.
Employees Shares Outstanding P/E

75
3 mill.
-
Revenue Growth Income Growth

MRQ Y/Y -99.33 %
MRQ Y/Y - %


TTOO

$0.2392

$-3.5808 -93.74%
Last 12 Months


TTOO

$0.2392

$-3.5808 -93.74%



T2 Biosystems Inc

T2 Biosystems Inc shares declined -93.74% over the past 12 months.


T2 Biosystems Inc operates on a business model centered around developing and commercializing innovative diagnostic solutions for medical purposes. Their technology relies on magnetic resonance for the detection of pathogens, toxins, and other molecules associated with various diseases. By offering rapid, accurate, and portable diagnostic capabilities, T2 Biosystems aims to improve patient outcomes and facilitate appropriate treatment decisions in healthcare settings.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 4.280 mill. $ 7.470 mill. $ -48.039 mill. 18 mill. - Y/Y 1.07 %
Market Cap. Revenues TTM Net Income TTM

$ 4.280 mill.
$ 7.470 mill.


$ -48.039 mill.
Employees Shares Outstanding P/E

60
18 mill.
-
Revenue Growth Income Growth

MRQ Y/Y 1.07 %
MRQ Y/Y - %


VGX-USD

$0.0099

$-0.1020 -91.15%
Last 12 Months


VGX-USD

$0.0099

$-0.1020 -91.15%



Voyager Token

Voyager Token shares declined -91.15% over the past 12 months.





Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 0.177 mill. $ 7.470 mill. $ -48.039 mill. 18 mill. - Y/Y 1.07 %
Market Cap. Revenues TTM Net Income TTM

$ 0.177 mill.
$ 7.470 mill.


$ -48.039 mill.
Employees Shares Outstanding P/E

-
18 mill.
-
Revenue Growth Income Growth

MRQ Y/Y 1.07 %
MRQ Y/Y - %


VVPR

$1.1299

$-11.1701 -90.81%
Last 12 Months


VVPR

$1.1299

$-11.1701 -90.81%



Vivopower International Plc

Vivopower International Plc shares declined -90.81% over the past 12 months.


Vivopower International Plc operates as a sustainable energy solutions provider that specializes in the development, construction, and operation of renewable energy projects globally. The company focuses on solar energy, battery storage, and energy efficiency solutions for commercial, industrial, and utility clients. Vivopower aims to create long-term value by delivering reliable, cost-effective, and environmentally-friendly energy solutions to its customers.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 16.187 mill. $ 10.738 mill. $ -24.355 mill. 14 mill. - Y/Y -47.79 %
Market Cap. Revenues TTM Net Income TTM

$ 16.187 mill.
$ 10.738 mill.


$ -24.355 mill.
Employees Shares Outstanding P/E

200
14 mill.
-
Revenue Growth Income Growth

MRQ Y/Y -47.79 %
MRQ Y/Y - %


VTAK

$0.4325

$-4.1685 -90.60%
Last 12 Months


VTAK

$0.4325

$-4.1685 -90.60%



Catheter Precision Inc

Catheter Precision Inc stock dropped -90.60% over the past 12 months.


Catheter Precision Inc is a medical device manufacturing company that specializes in the production of catheters and related components. The company follows a business-to-business (B2B) model, supplying its products to healthcare institutions, hospitals, and other medical device companies. With its focus on precision and quality, Catheter Precision Inc aims to provide innovative and reliable solutions for various medical procedures involving catheters.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 0.887 mill. $ 0.399 mill. $ -11.684 mill. 2 mill. - Y/Y -27.82 %
Market Cap. Revenues TTM Net Income TTM

$ 0.887 mill.
$ 0.399 mill.


$ -11.684 mill.
Employees Shares Outstanding P/E

50
2 mill.
-
Revenue Growth Income Growth

MRQ Y/Y -27.82 %
MRQ Y/Y - %


LRCX

$80.91

$-767.2500 -90.46%
Last 12 Months


LRCX

$80.91

$-767.2500 -90.46%



Lam Research Corporation

Lam Research Corporation shares declined -90.46% over the past 12 months.


Lam Research Corporation operates as a global supplier of wafer fabrication equipment and services to the semiconductor industry, providing advanced solutions for the manufacturing of high-performance integrated circuits. The company primarily generates revenue through the sale, service, and support of its equipment, along with long-term contracts with semiconductor manufacturers.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 105,511.980 mill. $ 15,590.772 mill. $ 4,056.818 mill. 1,304 mill. 26.12 Y/Y 19.70 %
Market Cap. Revenues TTM Net Income TTM

$ 105,511.980 mill.
$ 15,590.772 mill.


$ 4,056.818 mill.
Employees Shares Outstanding P/E

17,450
1,304 mill.
26.12
Revenue Growth Income Growth

MRQ Y/Y 19.70 %
MRQ Y/Y 25.81 %


WISA

$1.34

$-12.7000 -90.46%
Last 12 Months


WISA

$1.34

$-12.7000 -90.46%



Wisa Technologies inc

Wisa Technologies Inc shares declined -90.46% over the past 12 months.


Wisa Technologies Inc has a business model centered around developing and providing innovative wireless audio solutions to enhance the overall user experience. They aim to combine cutting-edge technology with seamless connectivity to empower users with high-quality audio solutions in various applications.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 7.073 mill. $ 2.192 mill. $ -59.508 mill. 5 mill. - Y/Y 52.41 %
Market Cap. Revenues TTM Net Income TTM

$ 7.073 mill.
$ 2.192 mill.


$ -59.508 mill.
Employees Shares Outstanding P/E

-
5 mill.
-
Revenue Growth Income Growth

MRQ Y/Y 52.41 %
MRQ Y/Y - %


VRPX

$0.297

$-2.7400 -90.22%
Last 12 Months


VRPX

$0.297

$-2.7400 -90.22%



Virpax Pharmaceuticals Inc

Virpax Pharmaceuticals Inc shares went down -90.22% over the past 12 months.


Virpax Pharmaceuticals Inc is a biopharmaceutical company that focuses on developing and commercializing innovative non-opioid products to address the unmet needs in pain management. Their business model revolves around research, development, and commercialization of these non-opioid solutions to provide effective and safe pain relief options for patients.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 1.383 mill. $ - mill. $ -14.672 mill. 5 mill. - Y/Y - %
Market Cap. Revenues TTM Net Income TTM

$ 1.383 mill.
$ - mill.


$ -14.672 mill.
Employees Shares Outstanding P/E

6
5 mill.
-
Revenue Growth Income Growth

MRQ Y/Y - %
MRQ Y/Y - %


VINC

$0.1141

$-1.0259 -89.99%
Last 12 Months


VINC

$0.1141

$-1.0259 -89.99%



Vincerx Pharma Inc

Vincerx Pharma Inc stock dropped -89.99% over the past 12 months.


Vincerx Pharma Inc*s business model is focused on developing and commercializing novel small molecule drugs for the treatment of cancer. They aim to leverage their scientific expertise and collaborations to identify and advance promising drug candidates, ultimately providing innovative therapies to patients in need.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 5.211 mill. $ - mill. $ -27.030 mill. 46 mill. - Y/Y - %
Market Cap. Revenues TTM Net Income TTM

$ 5.211 mill.
$ - mill.


$ -27.030 mill.
Employees Shares Outstanding P/E

17
46 mill.
-
Revenue Growth Income Growth

MRQ Y/Y - %
MRQ Y/Y - %


UPXI

$3.281

$-22.8190 -87.43%
Last 12 Months


UPXI

$3.281

$-22.8190 -87.43%



Upexi Inc

Upexi Inc shares went down -87.43% over the past 12 months.


Upexi Inc is a technology-driven company that operates on a platform-based business model. They provide a wide range of services through their platform, connecting customers with various service providers. Their revenue is generated through commissions or transaction fees earned from the services provided on their platform.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 3.430 mill. $ 67.977 mill. $ -10.391 mill. 1 mill. - Y/Y -75.54 %
Market Cap. Revenues TTM Net Income TTM

$ 3.430 mill.
$ 67.977 mill.


$ -10.391 mill.
Employees Shares Outstanding P/E

82
1 mill.
-
Revenue Growth Income Growth

MRQ Y/Y -75.54 %
MRQ Y/Y - %


TOVX

$1.44

$-9.6550 -87.02%
Last 12 Months


TOVX

$1.44

$-9.6550 -87.02%



Theriva Biologics inc

Theriva Biologics Inc shares dropped -87.02% over the past 12 months.


Theriva Biologics Inc operates as a biotechnology company that focuses on the discovery, development, and commercialization of innovative and targeted therapies for various diseases. Their business model is centered around research and development, aiming to create new biologic drugs and bring them to the market to address unmet medical needs.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 0.988 mill. $ - mill. $ -19.267 mill. 1 mill. - Y/Y - %
Market Cap. Revenues TTM Net Income TTM

$ 0.988 mill.
$ - mill.


$ -19.267 mill.
Employees Shares Outstanding P/E

19
1 mill.
-
Revenue Growth Income Growth

MRQ Y/Y - %
MRQ Y/Y - %


VRCA

$0.7132

$-4.7368 -86.91%
Last 12 Months


VRCA

$0.7132

$-4.7368 -86.91%



Verrica Pharmaceuticals Inc

Verrica Pharmaceuticals Inc shares declined -86.91% over the past 12 months.


Verrica Pharmaceuticals Inc is a biopharmaceutical company that focuses on developing and commercializing medical solutions for dermatological conditions. Their business model revolves around identifying unmet needs in the dermatology market, conducting rigorous clinical research to develop novel therapies, and efficiently bringing these treatments to market through strategic partnerships and collaborations. Verrica Pharmaceuticals aims to enhance patient outcomes by addressing specific dermatological conditions with innovative solutions.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 33.382 mill. $ - mill. $ -84.991 mill. 47 mill. - Y/Y - %
Market Cap. Revenues TTM Net Income TTM

$ 33.382 mill.
$ - mill.


$ -84.991 mill.
Employees Shares Outstanding P/E

41
47 mill.
-
Revenue Growth Income Growth

MRQ Y/Y - %
MRQ Y/Y - %


SPCE

$5.44

$-34.7600 -86.47%
Last 12 Months


SPCE

$5.44

$-34.7600 -86.47%



Virgin Galactic Holdings Inc

Virgin Galactic Holdings Inc shares declined -86.47% over the past 12 months.


Virgin Galactic Holdings Inc is a space tourism company that aims to provide suborbital flights to individuals seeking a unique space travel experience. Leveraging their space vehicles, they offer customers the opportunity to view Earth*s curvature and experience weightlessness during short-duration trips. Their revenue stems from ticket sales, in addition to potential partnerships and collaborations in the future.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 152.173 mill. $ 9.416 mill. $ -374.311 mill. 28 mill. - Y/Y -76.74 %
Market Cap. Revenues TTM Net Income TTM

$ 152.173 mill.
$ 9.416 mill.


$ -374.311 mill.
Employees Shares Outstanding P/E

677
28 mill.
-
Revenue Growth Income Growth

MRQ Y/Y -76.74 %
MRQ Y/Y - %


DFI-USD

$0.0177

$-0.1069 -85.79%
Last 12 Months


DFI-USD

$0.0177

$-0.1069 -85.79%



DeFiChain

Defichain stock dropped -85.79% over the past 12 months.





Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 0.495 mill. $ 9.416 mill. $ -374.311 mill. 28 mill. - Y/Y -76.74 %
Market Cap. Revenues TTM Net Income TTM

$ 0.495 mill.
$ 9.416 mill.


$ -374.311 mill.
Employees Shares Outstanding P/E

-
28 mill.
-
Revenue Growth Income Growth

MRQ Y/Y -76.74 %
MRQ Y/Y - %


TNON

$1.78

$-9.1800 -83.76%
Last 12 Months


TNON

$1.78

$-9.1800 -83.76%



Tenon Medical Inc

Tenon Medical Inc shares dropped -83.76% over the past 12 months.


Tenon Medical Inc is a healthcare company that operates on a subscription-based business model, providing medical services and products to subscribers. The company offers a range of medical solutions, including telemedicine consultations, prescription medications, and home delivery of healthcare supplies. Tenon Medical Inc generates revenue through monthly or annual subscription fees, complemented by additional revenue streams from sales of medical products.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 1.561 mill. $ 3.451 mill. $ -13.918 mill. 1 mill. - Y/Y 19.38 %
Market Cap. Revenues TTM Net Income TTM

$ 1.561 mill.
$ 3.451 mill.


$ -13.918 mill.
Employees Shares Outstanding P/E

36
1 mill.
-
Revenue Growth Income Growth

MRQ Y/Y 19.38 %
MRQ Y/Y - %


WOLF

$5.845

$-30.0750 -83.73%
Last 12 Months


WOLF

$5.845

$-30.0750 -83.73%



Wolfspeed Inc

Wolfspeed Inc stock dropped -83.73% over the past 12 months.


is an innovator of wide bandgap semiconductors


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 740.754 mill. $ 803.500 mill. $ -874.100 mill. 127 mill. - Y/Y -1.47 %
Market Cap. Revenues TTM Net Income TTM

$ 740.754 mill.
$ 803.500 mill.


$ -874.100 mill.
Employees Shares Outstanding P/E

5,013
127 mill.
-
Revenue Growth Income Growth

MRQ Y/Y -1.47 %
MRQ Y/Y - %


ZNTL

$2.1499

$-11.0101 -83.66%
Last 12 Months


ZNTL

$2.1499

$-11.0101 -83.66%



Zentalis Pharmaceuticals Inc

Zentalis Pharmaceuticals Inc stock dropped -83.66% over the past 12 months.


Zentalis Pharmaceuticals Inc is a biopharmaceutical company that focuses on the discovery and development of small molecule therapies for the treatment of various types of cancer. Their business model revolves around leveraging their expertise in drug discovery, conducting clinical trials, and ultimately commercializing effective cancer treatments. By leveraging their innovative research and development capabilities, Zentalis aims to address unmet medical needs and improve the lives of cancer patients worldwide.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 152.882 mill. $ - mill. $ -179.334 mill. 71 mill. - Y/Y - %
Market Cap. Revenues TTM Net Income TTM

$ 152.882 mill.
$ - mill.


$ -179.334 mill.
Employees Shares Outstanding P/E

168
71 mill.
-
Revenue Growth Income Growth

MRQ Y/Y - %
MRQ Y/Y - %


TTEC

$3.74

$-18.4000 -83.11%
Last 12 Months


TTEC

$3.74

$-18.4000 -83.11%



Ttec Holdings Inc

Ttec Holdings Inc stock declined -83.11% over the past 12 months.


Ttec Holdings Inc operates as a customer experience and technology services provider, offering solutions for businesses to enhance their customer interactions and improve customer satisfaction.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 178.996 mill. $ 2,243.106 mill. $ -313.440 mill. 48 mill. - Y/Y -11.82 %
Market Cap. Revenues TTM Net Income TTM

$ 178.996 mill.
$ 2,243.106 mill.


$ -313.440 mill.
Employees Shares Outstanding P/E

50,000
48 mill.
-
Revenue Growth Income Growth

MRQ Y/Y -11.82 %
MRQ Y/Y - %


WLDS

$1.275

$-6.1150 -82.75%
Last 12 Months


WLDS

$1.275

$-6.1150 -82.75%



Wearable Devices Ltd

Wearable Devices Ltd stock dropped -82.75% over the past 12 months.


Wearable Devices Ltd is a company that designs and manufactures wearable technology products, such as smartwatches and fitness trackers. They generate revenue by selling these devices directly to consumers through various retail channels, while also offering additional services and apps to enhance the user experience and create a recurring revenue stream.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 1.033 mill. $ 0.082 mill. $ -7.814 mill. 1 mill. - Y/Y 82.22 %
Market Cap. Revenues TTM Net Income TTM

$ 1.033 mill.
$ 0.082 mill.


$ -7.814 mill.
Employees Shares Outstanding P/E

50
1 mill.
-
Revenue Growth Income Growth

MRQ Y/Y 82.22 %
MRQ Y/Y - %


TSBX

$0.4558

$-2.1842 -82.73%
Last 12 Months


TSBX

$0.4558

$-2.1842 -82.73%



Turnstone Biologics Corp

Turnstone Biologics Corp shares dropped -82.73% over the past 12 months.


Turnstone Biologics Corp is a biotechnology company that focuses on developing innovative cancer treatments. Their business model includes leveraging their proprietary vaccinia virus-based platform to engineer oncolytic viral immunotherapies. These therapies are designed to selectively target and destroy cancer cells while also activating the patient*s immune system to generate a lasting anti-tumor response.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 10.501 mill. $ - mill. $ -19.147 mill. 23 mill. - Y/Y - %
Market Cap. Revenues TTM Net Income TTM

$ 10.501 mill.
$ - mill.


$ -19.147 mill.
Employees Shares Outstanding P/E

50
23 mill.
-
Revenue Growth Income Growth

MRQ Y/Y - %
MRQ Y/Y - %


ULY

$0.47

$-1.9750 -80.78%
Last 12 Months


ULY

$0.47

$-1.9750 -80.78%



Urgent ly Inc

Urgent Ly Inc stock dropped -80.78% over the past 12 months.


Urgently Inc*s business model is focused on providing urgent and on-demand services to customers through a mobile application or platform.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 6.310 mill. $ 249.481 mill. $ 68.286 mill. 13 mill. 0.01 Y/Y -21.28 %
Market Cap. Revenues TTM Net Income TTM

$ 6.310 mill.
$ 249.481 mill.


$ 68.286 mill.
Employees Shares Outstanding P/E

-
13 mill.
0.01
Revenue Growth Income Growth

MRQ Y/Y -21.28 %
MRQ Y/Y - %


CTXR

$3.1

$-12.9025 -80.63%
Last 12 Months


CTXR

$3.1

$-12.9025 -80.63%



Citius Pharmaceuticals Inc

Citius Pharmaceuticals Inc stock dropped -80.63% over the past 12 months.


Citius Pharmaceuticals Inc. is a biopharmaceutical company focused on developing and commercializing innovative therapies for a wide range of medical conditions. Their business model revolves around identifying unmet medical needs, conducting research and development to create novel drugs, and obtaining regulatory approvals for these drugs to bring them to market. They primarily aim to provide effective treatment options to patients and achieve commercial success through strategic partnerships and collaborations within the pharmaceutical industry.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 21.558 mill. $ - mill. $ -39.765 mill. 7 mill. - Y/Y - %
Market Cap. Revenues TTM Net Income TTM

$ 21.558 mill.
$ - mill.


$ -39.765 mill.
Employees Shares Outstanding P/E

35
7 mill.
-
Revenue Growth Income Growth

MRQ Y/Y - %
MRQ Y/Y - %


ABQQ

$0.0005

$-0.0020 -80.00%
Last 12 Months


ABQQ

$0.0005

$-0.0020 -80.00%



Ab International Group Corp

Ab International Group Corp stock dropped -80.00% over the past 12 months.


AB International Group Corp is a multinational holding company that primarily operates in the technology and logistics sectors. It leverages its diverse portfolio of subsidiaries to invest, acquire, and develop businesses that provide innovative solutions and services to various industries worldwide.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 1.141 mill. $ 3.125 mill. $ 0.448 mill. 2,281 mill. 2.08 Y/Y -21.88 %
Market Cap. Revenues TTM Net Income TTM

$ 1.141 mill.
$ 3.125 mill.


$ 0.448 mill.
Employees Shares Outstanding P/E

-
2,281 mill.
2.08
Revenue Growth Income Growth

MRQ Y/Y -21.88 %
MRQ Y/Y - %


ZVSA

$1.34

$-5.1590 -79.38%
Last 12 Months


ZVSA

$1.34

$-5.1590 -79.38%



Zyversa Therapeutics Inc

Zyversa Therapeutics Inc stock declined -79.38% over the past 12 months.


Zyversa Therapeutics Inc*s business model revolves around developing innovative therapies and treatments for various medical conditions.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 1.324 mill. $ - mill. $ 60.697 mill. 1 mill. - Y/Y - %
Market Cap. Revenues TTM Net Income TTM

$ 1.324 mill.
$ - mill.


$ 60.697 mill.
Employees Shares Outstanding P/E

-
1 mill.
-
Revenue Growth Income Growth

MRQ Y/Y - %
MRQ Y/Y - %


TIVC

$0.2779

$-1.0321 -78.79%
Last 12 Months


TIVC

$0.2779

$-1.0321 -78.79%



Tivic Health Systems Inc

Tivic Health Systems Inc shares went down -78.79% over the past 12 months.


Tivic Health Systems Inc is a company that operates on a direct-to-consumer business model. They develop and sell at-home medical devices for various health conditions, providing customers with the convenience of accessing healthcare solutions from the comfort of their own homes. By cutting out intermediaries and selling directly to consumers, Tivic Health Systems aims to deliver their products more efficiently and establish a direct relationship with their customers.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 1.721 mill. $ 0.957 mill. $ 1.823 mill. 6 mill. - Y/Y -55.32 %
Market Cap. Revenues TTM Net Income TTM

$ 1.721 mill.
$ 0.957 mill.


$ 1.823 mill.
Employees Shares Outstanding P/E

20
6 mill.
-
Revenue Growth Income Growth

MRQ Y/Y -55.32 %
MRQ Y/Y - %


TPST

$0.8594

$-3.0806 -78.19%
Last 12 Months


TPST

$0.8594

$-3.0806 -78.19%



Tempest Therapeutics Inc

Tempest Therapeutics Inc stock dropped -78.19% over the past 12 months.


Tempest Therapeutics Inc is a biotechnology company focused on developing small molecule therapeutics to treat cancer and other diseases. Their business model revolves around identifying novel targets within the immune system and designing drugs that modulate these targets to enhance the body*s immune response against cancer cells. Through strategic collaborations and partnerships, they aim to accelerate the development and commercialization of their product candidates.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 22.178 mill. $ - mill. $ -35.518 mill. 26 mill. - Y/Y - %
Market Cap. Revenues TTM Net Income TTM

$ 22.178 mill.
$ - mill.


$ -35.518 mill.
Employees Shares Outstanding P/E

14
26 mill.
-
Revenue Growth Income Growth

MRQ Y/Y - %
MRQ Y/Y - %


VERB

$5.8

$-20.7600 -78.16%
Last 12 Months


VERB

$5.8

$-20.7600 -78.16%



Verb Technology Company Inc

Verb Technology Company Inc stock declined -78.16% over the past 12 months.


Verb Technology Company Inc operates on a business model that involves developing and providing interactive video technology solutions for businesses. They focus on creating customizable video platforms that enhance customer engagement, sales, and marketing efforts for their clients.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 0.021 mill. $ 0.172 mill. $ -10.155 mill. 0 mill. - Y/Y 341.38 %
Market Cap. Revenues TTM Net Income TTM

$ 0.021 mill.
$ 0.172 mill.


$ -10.155 mill.
Employees Shares Outstanding P/E

133
0 mill.
-
Revenue Growth Income Growth

MRQ Y/Y 341.38 %
MRQ Y/Y - %


TNGX

$3.02

$-9.5500 -75.97%
Last 12 Months


TNGX

$3.02

$-9.5500 -75.97%



Tango Therapeutics Inc

Tango Therapeutics Inc stock dropped -75.97% over the past 12 months.


Tango Therapeutics Inc is a biotechnology company that focuses on developing cancer therapies using DNA sequencing and computational biology. Their business model revolves around discovering and developing precision medicines by leveraging their expertise in genomics and biology to target specific cancer vulnerabilities.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 327.692 mill. $ 43.384 mill. $ -123.395 mill. 109 mill. - Y/Y 8.15 %
Market Cap. Revenues TTM Net Income TTM

$ 327.692 mill.
$ 43.384 mill.


$ -123.395 mill.
Employees Shares Outstanding P/E

60
109 mill.
-
Revenue Growth Income Growth

MRQ Y/Y 8.15 %
MRQ Y/Y - %


WW

$1.055

$-3.3150 -75.86%
Last 12 Months


WW

$1.055

$-3.3150 -75.86%



Ww International Inc

Ww International Inc shares declined -75.86% over the past 12 months.


WW International Inc, formerly known as Weight Watchers International, operates on a subscription-based business model, offering weight management and wellness services to its members. They provide a comprehensive program that combines personalized coaching, digital tools, community support, and healthy living products. Their revenue is mainly generated through membership fees and the sale of their branded products.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 84.117 mill. $ 815.402 mill. $ -67.327 mill. 80 mill. - Y/Y -14.89 %
Market Cap. Revenues TTM Net Income TTM

$ 84.117 mill.
$ 815.402 mill.


$ -67.327 mill.
Employees Shares Outstanding P/E

4,850
80 mill.
-
Revenue Growth Income Growth

MRQ Y/Y -14.89 %
MRQ Y/Y - %


ANT-USD

$1.377

$-4.2281 -75.43%
Last 12 Months


ANT-USD

$1.377

$-4.2281 -75.43%



Aragon

Aragon stock went down -75.43% over the past 12 months.





Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 109.791 mill. $ 815.402 mill. $ -67.327 mill. 80 mill. - Y/Y -14.89 %
Market Cap. Revenues TTM Net Income TTM

$ 109.791 mill.
$ 815.402 mill.


$ -67.327 mill.
Employees Shares Outstanding P/E

-
80 mill.
-
Revenue Growth Income Growth

MRQ Y/Y -14.89 %
MRQ Y/Y - %


VLX-USD

$0.0068

$-0.0192 -73.85%
Last 12 Months


VLX-USD

$0.0068

$-0.0192 -73.85%



Velas

Velas stock declined -73.85% over the past 12 months.





Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 0.542 mill. $ 815.402 mill. $ -67.327 mill. 80 mill. - Y/Y -14.89 %
Market Cap. Revenues TTM Net Income TTM

$ 0.542 mill.
$ 815.402 mill.


$ -67.327 mill.
Employees Shares Outstanding P/E

-
80 mill.
-
Revenue Growth Income Growth

MRQ Y/Y -14.89 %
MRQ Y/Y - %


SSP

$2.17

$-6.0800 -73.70%
Last 12 Months


SSP

$2.17

$-6.0800 -73.70%



The E w Scripps Company

The E W Scripps Company stock declined -73.70% over the past 12 months.


The E.W. Scripps Company operates as a diversified media company, focusing on creating and distributing content across various platforms. Their business model involves generating revenue through advertising and subscription fees, while continuously adapting their strategies to the evolving media landscape.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 366.665 mill. $ 2,397.162 mill. $ -204.931 mill. 169 mill. 31.00 Y/Y 14.08 %
Market Cap. Revenues TTM Net Income TTM

$ 366.665 mill.
$ 2,397.162 mill.


$ -204.931 mill.
Employees Shares Outstanding P/E

5,800
169 mill.
31.00
Revenue Growth Income Growth

MRQ Y/Y 14.08 %
MRQ Y/Y - %


TANH

$0.161

$-0.4440 -73.39%
Last 12 Months


TANH

$0.161

$-0.4440 -73.39%



Tantech Holdings Ltd

Tantech Holdings Ltd stock dropped -73.39% over the past 12 months.


Tantech Holdings Ltd operates as a renewable energy company that specializes in the manufacture and distribution of bamboo-based charcoal products. Their business model primarily revolves around the production and sale of bamboo charcoal air purifiers, fuel-efficient stoves, and various other environmental protection products. With a focus on utilizing sustainable and natural resources, Tantech aims to promote a healthier and greener lifestyle for its customers.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 0.446 mill. $ 47.318 mill. $ 5.018 mill. 3 mill. 0.08 Y/Y -11.54 %
Market Cap. Revenues TTM Net Income TTM

$ 0.446 mill.
$ 47.318 mill.


$ 5.018 mill.
Employees Shares Outstanding P/E

300
3 mill.
0.08
Revenue Growth Income Growth

MRQ Y/Y -11.54 %
MRQ Y/Y 94.01 %



 1 Day   Week  Current Month of January  30 Days 
Current Quarter Q1 of 2025  90 Days    Ytd    12 Months 




Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com